.jpeg)
Agilent Technologies introduced the Altura Ultra Inert HPLC Columns, a product that is specifically manufactured to satisfy the most stringent requirements of biotherapeutic applications
Welcure Drugs & Pharmaceuticals stated on Monday that its board has analyzed and approved a proposal from Singapore's Telexcell Trade Pte to obtain as much as 25% of the company. The board noted that Telexcell will be considered solely as a...
Indian Immunologicals Limited (IIL) has introduced a gE-deleted DIVA marker vaccine for IBR (Infectious Bovine Rhinotracheitis), which is India's first indigenous option for this endemic disease in cattle. The IBR vaccine has been developed...
Syngene International has achieved a successful scale-up of the synthesis of a new active pharmaceutical ingredient for vascular calcification inhibition, progressing from lab-scale proof-of-concept to commercial-scale good manufacturing...
Danish pharmaceutical giant Novo Nordisk is planning to introduce Ozempic (semaglutide) in India, a once-weekly injectable that was initially approved for type-2 diabetes but is getting recognition as a treatment for obesity
Zydus Lifesciences Ltd. has teamed up with Pinkathon, the largest women's run in India, to announce the 10th edition of the Mumbai Pinkathon on December 21, 2025, at MMRDA Grounds, BKC in Mumbai. The partnership aims to bring key messaging...
Evonik has announced the launch of MaxiPure Polysorbate 80, a highly pure surfactant specifically designed for injectable and biopharmaceutical formulations. Modified to satisfy the strict requirements of current pharmaceuticals development
Sandoz, a global leader in the supply of affordable medicines, announced the US market release of its generic iron sucrose injection, following the US Food and Drug Administration (FDA) approval made recently.
India and Mexico have opened up strategic talks that focus on expanding the Indian pharmaceutical industry's opportunities. The communication is designed to provide better access to cheaper drugs in Mexico
Sanofi has declared a new $625 million multi-year capital commitment to its venture arm, Sanofi Ventures, bringing its total managed assets to over $1.4 billion. This is a considerable enlargement of the evergreen venture fund as it firmly...
, CDSCO.jpg)